Drug Testing Locations - Lansford, PA

Drug Testing in Lansford, PA

Lansford, Pennsylvania Statistics

Lansford, part of Carbon County, saw a 15% increase in opioid overdoses from 2021 to 2022.

Carbon County, where Lansford is located, reported a 5% rise in drug-related hospital admissions in 2022.

In Lansford, PA, 40% of rehab admissions involved heroin as reported in the last annual survey.

The drug-related crime rate in Lansford, Carbon County, increased by 10% in 2022 compared to 2021.

Lansford, within Carbon County, had 30 arrests related to drug trafficking in 2022.

Carbon County, encompassing Lansford, logged a 12% increase in drug possession arrests in recent reports.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Lansford, PA & Drug Testing Policies

In Lansford, PA, employers across various sectors recognize the impact of drug abuse on workforce productivity and safety. As a result, many have instituted comprehensive drug testing policies to maintain a drug-free workplace. These policies commonly involve pre-employment and random testing to deter drug use among employees.

Local businesses comply with Pennsylvania's Drug-Free Workplace Program guidelines which offer a framework to maintain safety through regular training and employee support services. State labor guidelines available from the Pennsylvania Department of Labor & Industry ensure that employers implement fair practices during drug testing and subsequent disciplinary actions.

Government Efforts with Drug Problems in Lansford, PA

The government of Lansford, located in Carbon County, has been actively working to combat drug abuse through various initiatives. State support is harnessed through the Pennsylvania Department of Drug and Alcohol Programs, offering funding for local rehabs and prevention programs. DDAP facilitates community-based prevention efforts and outreach programs focusing on reducing drug addiction.

The county has also collaborated with federal agencies like the Drug Enforcement Administration (DEA), targeting drug trafficking routes affecting the region. Awareness campaigns, coupled with law enforcement's increased presence, aim to thwart both the supply and demand dynamics in Lansford and its surroundings. Such integrated efforts represent a commitment to getting the community back on track.

Local Drug Busts & News in Lansford, PA

Lansford, found in Carbon County, had several prominent drug busts over the past year. A significant operation in early 2023 led to the arrest of five individuals suspected of running a local drug trafficking ring. Authorities seized several kilograms of heroin and methamphetamine.

Another raid in August 2023 uncovered an illicit drug manufacturing lab in a residential neighborhood. Such events underline the persistent challenges faced by law enforcement in the area, emphasizing their continual efforts to dismantle local drug networks and safeguard the community. Collaborations with state and federal agencies were pivotal in the success of these operations.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Lansford, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

Council of Southeast Pennsylvania

Pennsylvania Recovery Organizations Alliance

Narconon Pennsylvania

Caron Treatment Centers

Treatment Centers Directory

Pennsylvania Association of County Drug and Alcohol Administrators

DDAP Provider Search

Rehab.com in Pennsylvania

Drug Testing Near Lansford, PA

Lehighton, PA

Park Crest, PA

Weatherly, PA

Jim Thorpe, PA

Kelayres, PA

McAdoo, PA

Tresckow, PA

Beaver Meadows, PA

Hometown, PA

Tamaqua, PA

Nesquehoning, PA

Coaldale, PA

Summit Hill, PA

Frequently Asked Questions

Customer Reviews